title: Methotrexate-induced lymphoproliferative disorder in a patient with Sézary syndrome.
authors.forename: Michelle
authors.initials: M
authors.lastname: Rodrigues
authors.forename: David
authors.initials: D
authors.lastname: Westerman
authors.forename: Stephen
authors.initials: S
authors.lastname: Lade
authors.forename: Christopher
authors.initials: C
authors.lastname: McCormack
authors.forename: H Miles
authors.initials: HM
authors.lastname: Prince
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001706:Biopsy; D018450:Disease Progression; D004854:Herpesvirus 4, Human / Q000378:metabolism*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008206:Lymphatic Diseases / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000139:chemically induced / Q000150:complications*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D011379:Prognosis; D012307:Risk Factors; D012751:Sezary Syndrome / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D008727:Methotrexate